ONCOZENE MICROSPHERES 40UM, 2ML, ONCOZENE MICROSPHERES 75UM, 2ML, ONCOZENE MICROSPHERES 100UM, 2ML, ONCOZENE MICROSPHERE— 510(k) K130307

Name: FDA 510(k) clearance K130307
Creator: U.S. Food and Drug Administration
Published: 2013-03-04

Substantially Equivalent

Celonova Biosciences, Inc.

FDA 510(k) clearance K130307 for ONCOZENE MICROSPHERES 40UM, 2ML, ONCOZENE MICROSPHERES 75UM, 2ML, ONCOZENE MICROSPHERES 100UM, 2ML, ONCOZENE MICROSPHERE, Substantially Equivalent on 2013-03-04. Applicant: Celonova Biosciences, Inc.. Device class: 2.

Clearance details

Applicant: Celonova Biosciences, Inc.
Product code: Code KRD
Device class: Class 2
Regulation: 21 CFR 870.3300
Advisory panel: Cardiovascular
Date received: 2013-02-07
Decision date: 2013-03-04
Decision: Substantially Equivalent
Clearance type: Special
Location: San Antonio, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KRD

view all

K252812 — UniPearls® Embolic Microspheres2026-07-31
K261488 — OBSIDIO Conformable Embolic2026-07-24
K261866 — Concerto Versa Detachable Coil2026-06-24
K260635 — HARBOR Occlusion Device2026-06-12
K260508 — LOBO Vascular Occlusion System2026-04-10

More clearances from Celonova Biosciences, Inc.

view all

Adverse events under product code KRD

product code KRD

Death: 119
Injury: 1,869
Malfunction: 7,015
Other: 1
Total: 9,004

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.